GDRX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Case

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to GDRX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Case

TD Cowen Reiterates Buy Rating on GoodRx Holdings Inc. (GDRX)

May 9, 2024 4:01 PM EDT

TD Cowen analyst Charles Rhyee reiterated a Buy rating and $14.00 price target on GoodRx Holdings Inc. (NASDAQ: GDRX)

The analyst comments "We update our model following 1Q24 results, where mgmt. raised its 2024 guidance for revenue to $800-$810M (from ~$800M) and adj.... More